[For the historic record, here is the entire first IPT website, just one page. It
was put on Tijuana Net for Dr. Perez Garcia 3 in 1996 or 1997. Only the email address,
office address, phone area code, and office hours have been
changed, along with some minor formatting.]
Cancer: Use of Biologic Response
Modifiers, insulin hormone, as a neo-adjuvant anticancer drug potentiator in the treatment
of some cancers.
Photo 1 : mammogram suggests
presence of infiltrating ductal carcinoma
accompanied by two palpable nodes in
the right axilla. (February 3,1989)
Photo 2: mammogram take after
completion of a 8 courses of
treatments with the insulin protocol
reveals complete regression of
axillary and breast masses.
Photo 3: Initial X-ray of left arm from a 3 year
diagnosed with Ewing's sarcoma of the bone
Photo 4: Follow-up X-ray of left arm, 8 years
Complete tumor regression has been achieved without surgery or radiotherapy in patients
with some types of cancer using insulin as a biological response modifier combined with
reduced doses of anticancer drugs. This treatment resulted in marked reduction of
dose-related side effects caused by the anticancer drugs.
Administering pharmacological doses of exogenous insulin to patients with some types of
cancer and, at the onset of hypoglycemia, follow this with low doses of anticancer drugs.
Drug potentiation results from an insulin induced increase in trans-membrane passage
allowing for greater intracellular concentration of drug. The technique has been pioneered
by the late Dr. Donato Perez Garcia, Sr., his son and grandson- Dr. Donato Perez Garcia
y Bellon and Dr. Donato Perez Garcia, working in Mexico. Their initial clinical
trials started back in 1948. Dr, SGA, of the Chicago Medical School, North
Chicago, Illinois has been following closely these technique, developed by the Dr. Perez,
since 1975. He has confirmed the safety and efficacy of the insulin as a neo-adjuvant
anticancer drug potentiator in the treatment of some cancer's producing dramatic complete
and long-term regression of tumor masses in all subjects without adverse effects and with
excellent cosmetic results in the case of breast cancer. Even Dr. M. Fink, from Klinikum
Furth in Germany, had good results with the treatment of metastatic cancer, using the
technique developed by the Dr. Perez, noticing a 70% decrease in the tumor volume
after a 10 day follow-up. (January 22,1992).
Dr. Donato Perez Garcia
Tijuana, B.C. 22420 Mexico
Phone (from US): O11-52-(664)686-5473
FAX: (664) 686-1423
[Monday - Friday 9am - 5pm.
BY APPOINTMENT ONLY. ]
Scientific References -Medical Journals-:
Medica Militar 1938; volume 1, number 2:1-70. ; (2.-)Medical Hypotheses 20(2):199-210,
1986.; (3.-)Res Commun Chem Pathol Pharmacol 63(1):45-52,1989.; (4.-)Medical Hypotheses
29:283-291, i 989.; (5.-)European Journal of Cancer, 26,1262-1263, 1990.
Lectures at Scientific Conventions: (1.-)Forty-second Annual Symposium on
Fundamental Cancer Research, The University of Texas,M.D.Anderson Cancer Center, October
24-27,1989.; (2.-)Third International Congress on Neoadjuvant Chemotherapy, Paris, France,
February 6-9, 1991.
Historical Materials:(1.-) TIME Magazine article, April 10,1944.